Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Clinical Trial Comparing Oxaliplatin, Capecitabine and Hepatic Arterial Infusion of Floxuridine to Oxaliplatin and Capecitabine in Patients With Resected or Ablated Liver Metastases From Colorectal Cancer

NCT00268463 is registered in ClinicalTrials.gov with NSABP Foundation Inc as lead sponsor.

NCT NCT00268463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00268463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Clinical Trial Comparing Oxaliplatin, Capecitabine and Hepatic Arterial Infusion of Floxuridine to Oxaliplatin and Capecitabine in Patients With Resected or Ablated Liver Metastases From Colorectal Cancer
Lead sponsor
NSABP Foundation Inc
Phase
Phase 3
Overall status
Terminated
Start date
January 31, 2006
Completion date
June 30, 2008
Enrollment
22 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, metastatic cancer